|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2001-2-22
|
|
pubmed:abstractText |
Gemifloxacin and trovafloxacin were administered to 12 volunteers in a randomized crossover trial with a 2-week washout period. Stool samples were collected predose and 1, 2, and 3 days postdose. Both quinolones reduced the number of organisms of the family Enterobacteriaceae and aerobic gram-positive organisms. Escherichia coli reduction was greater with gemifloxacin than with trovafloxacin, with postdose isolation of quinolone-resistant strains for which MICs of trovafloxacin were higher than those of gemifloxacin.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/11158764-10471570,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11158764-10543756,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11158764-10553709,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11158764-2854456,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11158764-3300317,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11158764-3481248,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11158764-6236745,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11158764-6517559,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11158764-7559202,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11158764-7872757,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11158764-8203837,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11158764-9257749,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11158764-9360254,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11158764-9935254
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0066-4804
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
45
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
608-11
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Effects of single oral doses of gemifloxacin (320 milligrams) versus trovafloxacin (200 milligrams) on fecal flora in healthy volunteers.
|
|
pubmed:affiliation |
Department of Medical Microbiology, Fundación Jiménez Díaz, Madrid, Spain.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
